Old National Bancorp’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$307K Sell
493
-21
-4% -$14.3K 0.01% 486
2026
Q1
$397K Buy
514
+35
+7% +$26.8K 0.01% 433
2025
Q4
$370K Sell
479
-21
-4% -$14.3K 0.01% 429
2025
Q3
$281K Buy
+500
New +$283K ﹤0.01% 498
2024
Q4
Sell
-218
Closed -$229K 682
2024
Q3
$229K Sell
218
-60
-22% -$66.8K 0.01% 585
2024
Q2
$292K Buy
278
+4
+1% +$3.88K 0.01% 488
2024
Q1
$264K Buy
+274
New +$261K 0.01% 511
2020
Q3
Sell
-404
Closed -$252K 554
2020
Q2
$252K Sell
404
-255
-39% -$145K 0.01% 460
2020
Q1
$322K Sell
659
-679
-51% -$280K 0.02% 348
2019
Q4
$503K Sell
1,338
-10,315
-89% -$3.47M 0.02% 322
2019
Q3
$3.23M Sell
11,653
-68
-0.6% -$20.1K 0.16% 140
2019
Q2
$3.67M Buy
11,721
+516
+5% +$172K 0.19% 130
2019
Q1
$4.6M Buy
11,205
+1,740
+18% +$717K 0.24% 106
2018
Q4
$3.54M Buy
9,465
+2,510
+36% +$919K 0.2% 121
2018
Q3
$2.81M Buy
+6,955
New +$2.65M 0.14% 152

Other funds holding REGN

Old National Bancorp's REGN Position: Q2 2026 in Review

Old National Bancorp reduced its Regeneron Pharmaceuticals (REGN) stake by 4.1% in Q2 2026, selling an estimated $14.3K and leaving 493 shares worth $307K. The position accounts for 0.01% of the portfolio, ranked #486.

Old National Bancorp first reported a position in REGN in Q3 2018 and has held it in 15 quarters since. The position peaked at $4.6M in Q1 2019. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Old National Bancorp held 493 shares of Regeneron Pharmaceuticals worth $307K as of Q2 2026.
  • Old National Bancorp sold 21 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $14.3K.
  • Regeneron Pharmaceuticals made up 0.01% of Old National Bancorp's portfolio in Q2 2026, its #486 holding.
  • Old National Bancorp first reported a position in Regeneron Pharmaceuticals in Q3 2018 and has held it in 15 quarters since.
  • Old National Bancorp's Regeneron Pharmaceuticals position peaked at $4.6M in Q1 2019.
  • 334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Old National Bancorp's 13F filing for Q2 2026, filed 15 Jul 2026.